Abstracts
Showing 850 abstracts.
Citation
Long-distance mentorship program to build capacity of new investigators from resource-limited settings in HIV research. Presented at: 2nd International Workshop on HIV Pediatrics.Conference
2nd International Workshop on HIV Pediatrics
Citation
Joseph K. Wong, M.D., Ping Ruan, Ph.D., Kumud K. Singh, Yan Wang, Terence Fenton, Ed.D., Rodney Trout, B.S., Stephen A. Spector, M.D. IL-10-1082-G/A Promoter Variant Alters HIV Mother-to-child Transmission in African Mother-Infant Pairs Exposed to Zidovudine at Delivery. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Citation
Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Michael Hughes, Ph.D., Carmelita Alvero, William A. Meyer, III, Ph.D., Janice Hodge, R.N., B.S., Peggy R. Borum, Ph.D., John ( Jack ) Moye, Jr., M.D. Associations of Pro-Inflammatory Cytokine Levels with LIpid Profiles, Growth, and Body Compositions in HIV-Infected Children Initiating or Changing Antiretroviral Therapy. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Study
P1010
Citation
Sharon Appelbaum Nachman, M.D., Edward P. Acosta, Pharm.D., Pearl Samson, M.S., Hedy Teppler, M.D., Carolee Welebob, Terence Fenton, Ed.D., Edward Handelsman, M.D., Carol J. Worrell, M.D., Bobbie L. Graham, B.S., Andrew A. Wiznia, M.D. Pharmacokinetic (PK), Safety and Efficacy Data on Cohort IIA; youth aged 6-11 from IMPAACT P1066: A Phase I/II Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Study
P1066
Citation
Sarah Elizabeth Hudelson, B.S., M. McConnell, Danstan Bagenda, Estelle M. Piwowar-Manning, M.T. (A.S.C.P.), Teresa Parsons, Ph.D., Monica L. Nolan, P. Bakaki, M. Thigpen, Mary Glenn Fowler, M.D., M.P.H., Susan H. Eshleman, M.D., PH.D. Emergence and Persistence of Nevirapine-Resistant HIV in Breast Milk after Single-dose NVP Administration. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Citation
S Dross, Ingrid A. Beck, M.S., A Blanco, L Matunha, P Montoya, E Matediane, S Gloyd, S. Gantt, Lisa M. Frenkel, M.D. Transmission of Nevirapine (NVP)-resistant HIV-1 to Infants by Breastfeeding Observed After Maternal Single-dose NVP (sdNVP). Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Citation
Edmund Capparelli, Pharm.D., Alice M. Stek, M.D., Brookie M. Best, Pharm.D., Stephen J. Rossi, Pharm.D., Sandra K. Burchett, M.D., M.S., Haihong Li, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Elizabeth (Betsy) Smith, M.D., Elizabeth Hawkins, Michael T. Basar, B.S., Mark Mirochnick, M.D. Boosted FosAmprenavir Pharmacokinetics During Pregnancy. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Study
P1026S
Citation
Sharon Appelbaum Nachman, M.D., Adriana Weinberg, M.D., Petronella Muresan, M.S., Mark J. Abzug, M.D., Ruth Ebiasah, Pharm.D., M.S., R.Ph., Elizabeth Petzold, Ph.D., Barbara E. Heckman, B.S., Heather D. Watts, M.D., Judi A. Miller, R.N., B.S.N., Myron Levin, M.D. Safety of an Inactivated Influenza A (H1N1) Monovalent Vaccine (H1N1 Vaccine) in HIV-1 Infected Pregnant Women. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Study
P1086
Citation
M. J. Lindstrom, Laura A. Guay, M.D., Philippa Musoke, MB ChB, Maxensia Owor, M.B., CHB, MMED, Carol Onyango, M.D., Jessica D. Church, S. Omer, Brooks Jackson, M.D., M.B.A., Susan H. Eshleman, M.D., PH.D. Multi-class Drug Resistance Arises Frequently in HIV-infected Breastfeeding Infants Whose Mothers Initiate Highly Active Antiretroviral Therapy (HAART) Post-partum. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Citation
Sharon Appelbaum Nachman, M.D., Edward P. Acosta, Pharm.D., Pearl Samson, M.S., Hedy Teppler, M.D., B. Homony, Terence Fenton, Ed.D., Edward Handelsman, M.D., Carol J. Worrell, M.D., Bobbie L. Graham, B.S., Andrew A. Wiznia, M.D. Interim Results from P1066: Raltegravir (RAL) Oral Chewable Tablet (OCT) Formulation in Children 6-11 Years. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Study
P1066